Ask AI
ProCE Banner Activity

Metacure (B2 Cohorts): Phase II Trial of Intensified Hormonal Blockade With SBRT in Oligometastatic Castration-Sensitive Prostate Cancer

Conference Coverage
Slideset

In this analysis of results from the B2 and B2 Expansion cohorts of the phase II Metacure trial, SBRT with time-limited intensified hormonal blockade demonstrated a rapid recovery of testosterone and durable disease control in metachronous oligometastatic castration-sensitive prostate cancer.

Released: June 09, 2025

Expiration: December 08, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Astellas.

Astellas